Trial Profile
Efficacy of ibrutinib in patients with chronic lymphocytic leukemia: A real-world experience
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Feb 2024
Price :
$35
*
At a glance
- Drugs Ibrutinib (Primary)
- Indications Chronic lymphocytic leukaemia
- Focus Adverse reactions; Therapeutic Use
- 21 Sep 2016 New trial record